-Live Mint The first in a two-part series examining the opaque world of clinical trials in India A hospital in Indore has been able to get away with unethical medical trials in which 32 people have died over five years, according to the state government. This despite several investigations, a state government ban and Supreme Court strictures—a classic example of the lawless nature of the clinical trial business in India. Lata Mehra, who...
More »SEARCH RESULT
SC concerned over clinical trials of drugs, seeks details
-Deccan Herald The Supreme Court on Monday expressed concern over the lives of people who, without their knowledge, were subjected to drug clinical trials by pharma companies and sought details of the number of such trials and the deaths and adverse reactions caused by them over the last seven years. “We are concerned with the lives of those who become subjects of clinical trials unknowingly and helplessly,” ta bench of Justices R...
More »Bt Brinjal is safe, claims NIN
-The Times of India HYDERABAD: Is Bt Brinjal safe? The demonisation of BT crops got a push with the parliamentary committee on agriculture in its report submitted last month commenting that transgenics in food crops would be fraught with unknown consequences. But the Hyderabad-based National Institute of Nutrition (NIN) of the Indian Council of Medical Research (ICMR) says that Bt Brinjal is safe. A voluminous report on the laboratory experiments carried out...
More »Process of Clinical Trial to Be Streamlined Further: Govt
-PTI Procedures for clinical trials in India will be further streamlined and a panel of experts set up to analyse the cause of injury or death and to recommend quantum of compensation to victims, the Government today said. Replying to a Calling Attention Motion on the issue in Rajya Sabha, Health and Family Welfare Minister Ghulam Nabi Azad said the government proposed to strengthen the rules by incorporating certain new provisions soon. He...
More »Government warns PATH -Aarti Dhar
-The Hindu The government has issued a warning letter to Programme for Appropriate Technology in Health (PATH), asking it to be careful while conducting clinical trials so as to ensure that discrepancies and violations are not repeated in future. The Indian Council of Medical Research (ICMR) had suspended the Phase-V post licensure clinical trial being conducted by PATH, an international non-governmental organisation, in Khamman (Andhra Pradesh) and Vadodara (Gujarat) for Human Papilloma...
More »